TotalMarketCap

Connect Biopharma

CNTBNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$45.965 M

$0.73 -6.48%

Close of 6 Nov 2026

As of 6 Nov 2026, Connect Biopharma (CNTB) has a market capitalization of $46.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$64.0K

#3582 by revenue

Earnings

-$55.5M

Loss-making

Shares outstanding

62,974,309

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #341iBioIBIO$47.4M
  2. #342Citius OncologyCTOR$47.1M
  3. #343Connect BiopharmaCNTB$46.0M
  4. #344Mereo BioPharma GroupMREO$45.0M
  5. #345Biomea FusionBMEA$42.6M

What if Connect Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$448,387.20

Per share 614,313× higher

Bitcoin $1.53T

$24,261.45

Per share 33,239× higher

Apple $5.02T

$79,648.08

Per share 109,122× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Connect Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.